Bloomberg News reported on November 30, that Aspen is in “advanced discussions” for a licensing agreement to allow it to produce and sell a Covid-19 vaccine in Africa. The company previously said it was in talks with Johnson & Johnson about a licence that would mean that it could make its own-branded Covid-19 vaccine. Currently, Aspen has an agreement with Johnson & Johnson to package and fill vials of its vaccine at a plant in Gqeberha.

Other news